Core MRI technology provides most advanced scanners for highest
intraoperative image quality and best workflow available
WINNIPEG, Aug. 21, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
("IMRIS" or the "Company") today announced that the Company has
received Health Canada licensing to incorporate next generation MRI
core technology into the VISIUS Surgical Theatre for sales and
marketing in the country.
This newest imaging technology, based on the Siemens Aera 1.5T (Tesla)
and Skyra 3.0T MRI scanners, helps IMRIS deliver even better image
quality, faster 3D image acquisition, and improved ease-of-use and
workflow during surgical procedures using intraoperative MRI (iMRI).
The Company received United States Food and Drug Administration (FDA)
clearance for these advancements in February 2014 and last month
received CE mark authorization in Europe.
"Hospitals who adopt this technology in our VISIUS solution will have
access to the highest quality MR applications and images within the
operating room setting," said IMRIS President and CEO Jay D. Miller.
"This latest and unequaled imaging technology in the hands of
neurosurgeons is improving patient outcomes and making newer
minimally-invasive treatment options for brain tumors, epilepsy and
other therapies work better."
Inside a VISIUS Surgical Theatre equipped with high-field iMRI, surgeons
have on-demand access to real-time data and state-of-the-art imaging
during the procedure as the scanner uniquely moves on ceiling-mounted
rails. The Company also designs and manufactures proprietary
intraoperative CTs, head fixation devices, imaging coils, and OR tables
for use in this unique and multifunctional intraoperative environment.
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides
unmatched intraoperative vision to clinicians to assist in decision
making and enhance precision in treatment. The multi-room suites
incorporate diagnostic quality high-field MR, CT and angio modalities
accessed effortlessly in the operating room setting. VISIUS Surgical
Theatres serve the neurosurgical, spinal, cardiovascular and
cerebrovascular markets and have been selected by 61 leading medical
institutions around the world.
SOURCE: IMRIS Inc.
For further information:
Kevin J. Berger
Marketing Communications Manager